Antibody treatment, a technique commonly used to treat cancer, is showing promise in prevention, treatment, and even potentially curing HIV. A lot of work and research is still necessary to determine whether this approach can be clinically useful, with the main concerns being long-lasting efficacy and cost of treatment. HIV mutates rampantly with every replication and can evade antibodies, making treatment with a single antibody of limited effectiveness and unfortunately only temporary. HIV's mutation rate necessitates immunotherapy being made of a combination of antibodies, but this increases the cost as well. However, the cost of antiretroviral therapy has fallen in the past two decades, creating hope in cost reduction for antibody immunotherapy. Follow the link below to see the full article.